Member Info for Farris

TW spoke to soh regards to sweet and india deals, sounds pretty imminent.

I see Trustpilot reviews are coming in thick and fast, and all very positive.

Hi Elrico, I have just listened to the last Stuart Ashman video you did, the 2 part one.You asked him about the oral trial and what’s happening with results that were due end of summer, he didn’t actually give an answer, I’m hoping that’s because the results were positive and there’s a deal being done, do you know anymore than this, thanks

Turtlehead, I think you’re overthinking what people are saying, you said your an opti shareholder, so you must have a bit of patience, I don’t think you’re going to need as much patience with skin, now is the time to buy, get in now before transformational news, I don’t think a placing,if we do have one will have much affect ,medium term ,on the share price.

Thanks Elrico

Mol where did that come from?

Good interview by the way.

Oleric, dig not too deep, and then you can

Could have news next month, with regards to Croda study.

Would be interested to know how they promote the product, when they start selling into a new country, just to kickstart sales, any ideas?

Elrico,great interview, much appreciated,you asked everything i needed to know,

Your so much better than that other interviewer, what’s he’s face, Tom —Mmmmmm

Yes Elrico,how was the interview, come on spill the beans!

It’s a difficult one with the chewing gum, perfect for teenagers, easy to take, but is it going to line the stomach as well as a drink?

They question is guys and girls has the consumer study started, or has it not started, if it has started, are results imminent?

That can’t do any harm.

Thanks Elrico

Nice, news tomorrow then!!

Well done aqua, very interesting.

Elrico, what do you make of it, are acne results imminent,or recruitment imminent?

Aqua,I understand that recruitment has already taken place, and results are imminent, need clarification.

Also, we could be raising money very soon if this acquisition goes ahead.